logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

YSB (09885) repurchased 105,000 shares for HK$365,200 on September 15.

date
19:03 15/09/2026
avatar
GMT Eight
YSB (09885) announced that on September 15, 2026, the company repurchased 105,000 shares for HK$365,200, at a repurchase price of HK$3.445-3.535 per share.
YSB (09885) announced that on September 15, 2026, the company repurchased 105,000 shares for HK$365,200, at a repurchase price of HK$3.445-3.535 per share.
Related Articles
Preview of US Stock Market | All three major stock index futures fell together; the 10-year U.S. Treasury yield rose above 5%; crypto stocks declined in premarket trading.
China Stock
Northeast Pharmaceutical Group (000597.SZ): Empagliflozin Tablets Obtained Drug Registration Certificate
HK Stock
INFINITY DEV (00640) repurchased 4.548 million shares for HK$10.4954 million on September 15.
Preview of US Stock Market | All three major stock index futures fell together; the 10-year U.S. Treasury yield rose above 5%; crypto stocks declined in premarket trading.
Northeast Pharmaceutical Group (000597.SZ): Empagliflozin Tablets Obtained Drug Registration Certificate
China Stock
INFINITY DEV (00640) repurchased 4.548 million shares for HK$10.4954 million on September 15.
HK Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.